RVT-1201 A Phase 2a, Double-Blind Placebo-Controlled Multicenter Study to Assess the Safety tolerability pharmacokinetics and pharmacodynamic effects of RVT-1201 in Patients with PAH

Administered By

Contributors

Start/End

  • June 24, 2019 - May 31, 2021